Back to top

Moderna (MRNA) Receives a Hold from Barclays

Barclays analyst Eliana Merle maintained a Hold rating on Moderna today and set a price target of $48.00. According to TipRanks, Merle is a 3-star ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Moderna, Inc. (MRNA)